Clinical trials
Active, not recruiting Phase 3 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 13 |
| 2021 | 14 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 16 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 18 |
| Merck Sharp & Dohme LLC | 9 |
| Hoffmann-La Roche | 5 |
| National Cancer Institute (NCI) | 5 |
| Eli Lilly and Company | 4 |
| Janssen Research & Development, LLC | 4 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 4 |
| Daiichi Sankyo | 3 |
| Bristol-Myers Squibb | 2 |
| Gilead Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 97 |
| Lung Neoplasms | 15 |
| Neoplasm Metastasis | 4 |
| Carcinoma | 3 |
| Lung Diseases | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Ovarian Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.